[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2531692A1 - Utilisation de porphobilinogene synthase hexamere comme cible pour la mise au point d'antibiotiques et d'herbicides - Google Patents

Utilisation de porphobilinogene synthase hexamere comme cible pour la mise au point d'antibiotiques et d'herbicides Download PDF

Info

Publication number
CA2531692A1
CA2531692A1 CA002531692A CA2531692A CA2531692A1 CA 2531692 A1 CA2531692 A1 CA 2531692A1 CA 002531692 A CA002531692 A CA 002531692A CA 2531692 A CA2531692 A CA 2531692A CA 2531692 A1 CA2531692 A1 CA 2531692A1
Authority
CA
Canada
Prior art keywords
composition
multimeric
pbgs
porphobilinogen synthase
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002531692A
Other languages
English (en)
Inventor
Eileen K. Jaffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fox Chase Cancer Center
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2531692A1 publication Critical patent/CA2531692A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
CA002531692A 2003-07-07 2004-07-07 Utilisation de porphobilinogene synthase hexamere comme cible pour la mise au point d'antibiotiques et d'herbicides Abandoned CA2531692A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US48525303P 2003-07-07 2003-07-07
US60/485,253 2003-07-07
US57731204P 2004-06-04 2004-06-04
US60/577,312 2004-06-04
PCT/US2004/021722 WO2005007817A2 (fr) 2003-07-07 2004-07-07 Utilisation de porphobilinogene synthase hexamere comme cible pour la mise au point d'antibiotiques et d'herbicides

Publications (1)

Publication Number Publication Date
CA2531692A1 true CA2531692A1 (fr) 2005-01-27

Family

ID=34083333

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002531692A Abandoned CA2531692A1 (fr) 2003-07-07 2004-07-07 Utilisation de porphobilinogene synthase hexamere comme cible pour la mise au point d'antibiotiques et d'herbicides

Country Status (6)

Country Link
EP (1) EP1648429A4 (fr)
JP (1) JP2007529995A (fr)
AU (1) AU2004257208B2 (fr)
CA (1) CA2531692A1 (fr)
IL (1) IL173016A (fr)
WO (1) WO2005007817A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153410B2 (en) 2003-07-07 2012-04-10 Fox Chase Cancer Center Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
US20060162014A1 (en) * 2003-07-07 2006-07-20 Jaffe Eileen K Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999059606A1 (fr) * 1998-05-16 1999-11-25 Mogam Biotechnology Research Institute Emploi de l'acide romarinique et/ou de ses derives immunosuppresseur et/ou inhibiteur des processus induits par le sh2
JP4112730B2 (ja) * 1999-02-22 2008-07-02 オリザ油化株式会社 口腔用抗菌剤

Also Published As

Publication number Publication date
IL173016A (en) 2012-03-29
JP2007529995A (ja) 2007-11-01
IL173016A0 (en) 2006-06-11
WO2005007817A2 (fr) 2005-01-27
EP1648429A2 (fr) 2006-04-26
WO2005007817A3 (fr) 2005-11-03
EP1648429A4 (fr) 2009-09-02
AU2004257208A1 (en) 2005-01-27
AU2004257208B2 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
US8153410B2 (en) Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
Amorim Franco et al. Bacterial branched-chain amino acid biosynthesis: structures, mechanisms, and drugability
Laflamme et al. Molecular and biochemical analysis of a Madagascar periwinkle root-specific minovincinine-19-hydroxy-O-acetyltransferase
US6613553B1 (en) Enoyl reductases and methods of use thereof
Lu et al. Fatty acid synthesis as a target for antimalarial drug discovery
WO1999024586A1 (fr) Hydroxy-phenyl pyruvate dioxygenase chimere, sequence d'adn et obtention de plantes contenant un tel gene, tolerantes aux herbicides
US20110207816A1 (en) Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
CA2341412A1 (fr) Heparinases a conception rationnelle derivees de l'heparinase i et ii
JP6665281B2 (ja) 安定性が増加されたヒト繊維芽細胞成長因子−2変異体及びその用途
RU2652605C2 (ru) Блокада воспалительных протеаз тета-дефензинами
Supuran Carbonic anhydrases as drug targets—general presentation
AU2004257208B2 (en) Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides
WO2005007817A9 (fr) Utilisation de porphobilinogene synthase hexamere comme cible pour la mise au point d'antibiotiques et d'herbicides
US20240335476A1 (en) Systems and methods for the treatment of hemoglobinopathies
Moorefield et al. Characterization of a family I inorganic pyrophosphatase from Legionella pneumophila Philadelphia 1
EP1069911A1 (fr) Nitroreductase nouvelle et usages therapeutiques associes
JP3355368B2 (ja) 植物由来のエポキシド水解酵素をコードするcDNAを含むプラスミドベクターおよび形質転換体
CN113939586A (zh) 治疗β-地中海贫血症的方法
Peters-Golden The chemical elucidation of slow-reacting substance: bronchospasm and beyond
RU2437934C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ФРАКЦИИ ИЗ КЛЕТОК Escherichia coli, ОБЛАДАЮЩЕЙ ИНГИБИРУЮЩЕЙ ПРОТЕАЗЫ АКТИВНОСТЬЮ
CN1835739A (zh) 六聚体胆色素原合成酶作为开发抗生素和除草剂的靶
EP2337850A2 (fr) Composés anti-protozoaires
Parker Production and purification of imidazole glycerol phosphate dehydratase from Escherichia coli and Cryptococcus neoformans: Comparative kinetic and metal binding studies
JPH10505747A (ja) ヒトのイノシトールモノホスファターゼh1
EP1003848A2 (fr) Procedes d'activation de genes inactifs et procedes de modification de la vitesse de developpement de cellules, de tissus, et d'organismes

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130311